Functional association of the parkin gene promoter with idiopathic Parkinson's disease

Human Molecular Genetics

Volumn 11, Issue 22, 2002, Pages 2787-2792

  West, Andrew B ^a   Maraganore, Demetrius ^b   Crook, Julia ^a   Lesnick, Tim ^b   Lockhart, Paul J ^a   Wilkes, Kristen M ^a   Kapatos, Gregory ^c   Hardy, John A ^a   Farrer, Matt J ^d  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GUANINE; NUCLEAR PROTEIN; PARKIN; THYMINE;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HYPOTHESIS; IDIOPATHIC DISEASE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; ONSET AGE; PARKINSON DISEASE; PARKINSONISM; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANTIA NIGRA;

EID: 0037108727     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.22.2787     Document Type: Article

References (32)

1. Gelb, D.J., Oliver, E. and Gilman, S. (1999) Diagnostic criteria for Parkinson disease. Arch. Neurol., 56, 33-39.
2. Lücking, C., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B.S., Meco, G., Denefle, P., Wood, N.W. et al. (2000) Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N. Engl. J Med., 342, 1560-1567.
3. Valente, E.M., Brancati, F., Ferraris, A., Graham, E.A., Davis, M.B., Breteler, M.M., Gasser, T, Bonifati, V, Bentivoglio, A.R., De Michele, G. et al. (2002) Park6-linked parkinsonism occurs in several european families. Ann. Neurol., 51, 14-18.
4. Sveinbjornsdottir, S., Hicks, A.A., Jonsson, T., Petursson, H., Guomundsson, G., Frigge, M.L., Kong, A., Gulcher, J.R. and Stefansson, K. (2000) Familial aggregation of Parkinson's disease in Iceland. N. Engl. J. Med., 343, 1765-1770.
5. Maher, N.E., Golbe, L.I., Lazzarini, A.M., Mark, M.H., Currie, L.J., Wooten, G.F., Saint-Hilaire, M., Wilk, J.B., Valcjak, J., Maher, J.E. et al. (2002) Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology, 58, 79-84.
6. Scott, W.K., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, WC., Lyons, K., Pahwa, R., Stern, M.B., Colcher, A., Hiner, B.C. et al. (2001) Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA, 286, 2239-2244.
7. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y, Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605-608.
8. Abbas, N., Lücking, C.B., Ricard, S., Dürr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J.R., Gasser, T., Marconi, R. et al. (1999) A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. Hum. Mol. Genet., 8, 567-574.
9. Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn-Hardy, K., Petrucelli, L., Hussey, J. et al. (2001) Lewy bodies and parkinsonism in families with parkin mutations. Ann. Neurol., 50, 293-300.
10. Hilker, R., Klein, C., Ghaemi, M., Kis, B., Strotmann, T., Ozelius, L.J., Lenz, O., Vieregge, P., Herholz, K., Heiss, W.D. et al. (2001) Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann. Neurol., 49, 367-376.
11. West, A., Periquet, M., Lincoln, S., Lücking, C., Nicholl, D., Bonifati, V, Rawal N., Gasser, T., Lohmann, E., Deleuze, J. et al. (2002) Complex relationship between Parkin mutations and Parkinson disease. Am. J. Med. Genet., 114, 584-591.
12. Klein, C., Pramstaller, P.P., Kis, B., Page, C.C., Kann, M., Leung, J., Woodward, H., Castellan, C.C., Scherer, M, Vieregge, P. et al. (2000) Parkin deletions in a family with adult-onset tremor-dominant parkinsonism: expanding the phenotype. Ann. Neurol., 48, 65-71.
13. Maruyarna, M., Ikeuchi, T., Saito, M., Ishikawa, A., Yuasa, T., Tanaka, H., Hayashi, S., Wakabayashi, K., Takahashi, H. and Tsuji, S. (2000) Novel mutations, pseudo-dominant inheritance, and possible familial affects in patients with autosomal recessive juvenile parkinsonism. Ann. Neurol., 48, 245-250.
14. Hilker, R., Klein, C., Hedrich, K., Ozelius, L.J., Vieregge, P, Herholz, K., Pramstaller, P.P. and Heiss, W.D. (2002) The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans. Neurosci. Lett., 323, 50-54.
15. Farrer, M., Maraganore, D.M., Lockhart, P., Singleton, A., Lesnick, T.G., de Andrade, M., West, A., de Silva, R., Hardy, J. and Hernandez, D. (2001) α-Synuclein gene haplotypes are associated with Parkinson's disease. Hum. Mol. Genet., 10, 1847-1851.
16. Artiga, MJ, Bullido, M.J., Frank, A., Sastre, I., Recuero, M., Garcia, M.A., Lendon, C.L., Han, S.W, Morris, J.C., Vazquez, J. et al. (1998) Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Hum. Mol. Genet., 7. 1887-1892.
17. Chiba-Falek, O. and Nussbaum, R.L. (2001) Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum. Mol. Genet., 10, 3101-3109.
18. West, A., Farrer, M., Petrucelli, L., Cookson, M., Lockhart, P. and Hardy, J. (2001) Identification and characterization of the human parkin gene promoter. J. Neurochem., 78, 1146-1152.
19. Asakawa, S., Tsunematsu, K., Takayanagi, A., Sasaki, T., Shimizu, A., Shintani, A., Kawasaki, K., Mungall, A.J., Beck, S., Minoshima, S. et al. (2001) The genomic structure and promoter region of the human parkin gene. Biochem. Biophys. Res. Commun., 286, 863-868.
20. Quandt, K., Frech, K., Karas, H., Wingender, E. and Werner, T. (1995) MatInd and MatInspector. new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res., 23, 4878-4884.
21. 2+-binding protein regucalcin gene. Biochem. Biophys. Res. Commun., 269, 270-278.
22. Misawa, H. and Yamaguchi, M. (2000) Intracellular signaling factors-enhanced hepatic nuclear protein binding to TTGGC sequence in the rat regucalcin gene promoter: involvement of protein phosphorylation. Biochem. Blophys. Res. Commun., 279, 275-281.
23. Wang, M., Hattori, N., Matsumine, H., Kobayashi, T., Yoshino, H., Morioka, A., Kitada, T., Asakawa, S., Minoshima, S., Shimizu, N. et al. (1999) Polymorphism in the parkin gene in sporadic Parkinson's disease. Ann. Neurol., 45, 655-658.
24. Satoh, J. and Kuroda, Y. (1999) Association of codon 167 Ser/Asn heterozygosity in the parkin gene with sporadic Parkinson's disease. Neuroreport, 10, 2735-2739.
25. Mellick, G.D., Buchanan, D.D., Hattori, N., Brookes, A.J., Mizuno, Y., Le Couteur, D.G. and Silburn, P.A. (2001) The parkin gene S/N167 polymoxphism in Australian Parkinson's disease patients and controls. Parkinsonism Relat. Disord., 7, 89-91.
26. Oliveri, R.L., Zappia, M., Annesi, G., Bosco, D., Annesi, F., Spadafora, P., Pasqua, A.A., Tomaino, C., Nicoletti, G., Pirritano, D. et al. (2001) The parkin gene is not involved in late-onset Parkinson's disease. Neurology, 57, 359-362.
27. Hu, C.J., Sung, S.M., Liu, H.C., Lee, C.C., Tsai, C.H. and Chang, J.G. (2000) Polymorphisms of the parkin gene in sporadic Parkinson's disease among Chinese in Taiwan. Eur. Neurol., 44, 90-93.
28. Terwilliger, J.D. and Weiss, K.M. (1998) Linkage disequilibrium mapping of complex disease: fantasy or reality? Curr. Opin. Biotechnol., 9, 578-594.
29. Ioannidis, J.P., Ntzani, E.E., Trikalinos, T.A. and Contopoulos-Ioannidis, D.G. (2001) Replication validity of genetic association studies. Nat. Genet, 29, 306-309.
30. Maraganore, D.M., Farrer, M.J., Hardy, J.A., Lincoln, S.J., McDonnell, S.K. and Rocca, W.A. (1999) Case-control study of the ubiquitin carboxyterminal hydrolase L1 gene in Parkinson's disease. Neurology, 53, 1858-1860.
31. Maraganore, D.M., Hernandez, D.G., Singleton, A.B., Farrer, M.J., McDonnell, S.K., Hutton, M.L., Hardy, J.A. and Rocca, W.A. (2001) Case-control study of the extended tau gene haplotype in Parkinson's disease. Ann. Neurol., 50, 658-661.
32. Breslow, N.E. and Day, N.E. (1980) Statistical Methods in Cancer Research. Vol I-The Analysis of Case-Control Studies. IARC Press, Lyon.